Company / Working Capital per Share
ArriVent BioPharma, Inc. Working Capital per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.66
FY2024
5-year range
$6.66 / $69.29
FY2023-FY2024
Trend
-90.4%
vs FY2023
Sector context
#81 of 210
Health Care
What the data says
At $6.66, ArriVent BioPharma, Inc.'s working capital per share ranks #81 of 210 in the Health Care sector.
Based on SEC 10-K filings.
6.66 in FY2024.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#81 of 210 in Health CareTop 39% of 210This company $6.66 Sector average $146.86
▼
-95.5% below sector average
Key checks
Key Insights
- In FY2024, working capital per share decreased 90.4% year-over-year.
- Ranks #81 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.66 | -90.4% |
| FY2023 | $69.29 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026